(R)-Ketorolac

cell division cycle 42 ; Homo sapiens







6 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 33413202 The R-enantiomer of ketorolac reduces ovarian cancer tumor burden in vivo. 2021 Jan 7 1
2 33861592 Molecular Mechanisms of the Blockage of Glioblastoma Motility. 2021 Jun 28 1
3 31344967 Dual Actions of Ketorolac in Metastatic Ovarian Cancer. 2019 Jul 24 1
4 29169987 The R-Enantiomer of Ketorolac Delays Mammary Tumor Development in Mouse Mammary Tumor Virus-Polyoma Middle T Antigen (MMTV-PyMT) Mice. 2018 Feb 3
5 26071482 A Novel Pharmacologic Activity of Ketorolac for Therapeutic Benefit in Ovarian Cancer Patients. 2015 Nov 15 1
6 26206334 R-Ketorolac Targets Cdc42 and Rac1 and Alters Ovarian Cancer Cell Behaviors Critical for Invasion and Metastasis. 2015 Oct 6